nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—RIPK2—ulcerative colitis	0.288	0.567	CbGaD
Dasatinib—JAK2—ulcerative colitis	0.194	0.383	CbGaD
Dasatinib—ABCB1—ulcerative colitis	0.0249	0.0491	CbGaD
Dasatinib—CYP1A1—Nicotine—ulcerative colitis	0.017	0.0972	CbGbCtD
Dasatinib—CYP1A1—Cholecalciferol—ulcerative colitis	0.0153	0.0872	CbGbCtD
Dasatinib—CYP1B1—Dexamethasone—ulcerative colitis	0.0151	0.086	CbGbCtD
Dasatinib—ABCG2—Sulfasalazine—ulcerative colitis	0.0144	0.0819	CbGbCtD
Dasatinib—ABCG2—Hydrocortisone—ulcerative colitis	0.0115	0.0658	CbGbCtD
Dasatinib—CYP3A4—Budesonide—ulcerative colitis	0.00916	0.0523	CbGbCtD
Dasatinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.00796	0.0454	CbGbCtD
Dasatinib—CYP1A2—Nicotine—ulcerative colitis	0.00761	0.0434	CbGbCtD
Dasatinib—ABCG2—Dexamethasone—ulcerative colitis	0.00717	0.0409	CbGbCtD
Dasatinib—ABCB1—Methylprednisolone—ulcerative colitis	0.00683	0.039	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—ulcerative colitis	0.00662	0.0377	CbGbCtD
Dasatinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.00638	0.0364	CbGbCtD
Dasatinib—ABCB1—Betamethasone—ulcerative colitis	0.00444	0.0253	CbGbCtD
Dasatinib—ABCB1—Prednisolone—ulcerative colitis	0.00438	0.025	CbGbCtD
Dasatinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00416	0.0237	CbGbCtD
Dasatinib—ABCB1—Prednisone—ulcerative colitis	0.00414	0.0236	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00409	0.0234	CbGbCtD
Dasatinib—CYP3A4—Nicotine—ulcerative colitis	0.00399	0.0228	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—ulcerative colitis	0.00397	0.0227	CbGbCtD
Dasatinib—KIT—myenteric nerve plexus—ulcerative colitis	0.00369	0.0589	CbGeAlD
Dasatinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00358	0.0204	CbGbCtD
Dasatinib—CYP3A4—Triamcinolone—ulcerative colitis	0.0031	0.0177	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—ulcerative colitis	0.00266	0.0152	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—ulcerative colitis	0.00263	0.015	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—ulcerative colitis	0.00258	0.0147	CbGbCtD
Dasatinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00249	0.0142	CbGbCtD
Dasatinib—CYP3A4—Prednisone—ulcerative colitis	0.00248	0.0142	CbGbCtD
Dasatinib—WEE2—lymphoid tissue—ulcerative colitis	0.00173	0.0277	CbGeAlD
Dasatinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00155	0.00883	CbGbCtD
Dasatinib—TEC—lymphoid tissue—ulcerative colitis	0.00131	0.021	CbGeAlD
Dasatinib—BMX—epithelium—ulcerative colitis	0.00112	0.018	CbGeAlD
Dasatinib—STAT5B—epithelium—ulcerative colitis	0.000997	0.0159	CbGeAlD
Dasatinib—TEC—liver—ulcerative colitis	0.000967	0.0154	CbGeAlD
Dasatinib—FRK—lymphoid tissue—ulcerative colitis	0.000888	0.0142	CbGeAlD
Dasatinib—BLK—lymphoid tissue—ulcerative colitis	0.000856	0.0137	CbGeAlD
Dasatinib—EPHB2—lymphoid tissue—ulcerative colitis	0.000847	0.0135	CbGeAlD
Dasatinib—EPHB2—digestive system—ulcerative colitis	0.000837	0.0134	CbGeAlD
Dasatinib—TXK—lymphoid tissue—ulcerative colitis	0.00082	0.0131	CbGeAlD
Dasatinib—SRMS—digestive system—ulcerative colitis	0.000819	0.0131	CbGeAlD
Dasatinib—PTK6—digestive system—ulcerative colitis	0.000802	0.0128	CbGeAlD
Dasatinib—BMPR1B—epithelium—ulcerative colitis	0.000799	0.0128	CbGeAlD
Dasatinib—STAT5B—lymphoid tissue—ulcerative colitis	0.000768	0.0123	CbGeAlD
Dasatinib—EPHB1—liver—ulcerative colitis	0.000759	0.0121	CbGeAlD
Dasatinib—STAT5B—digestive system—ulcerative colitis	0.000758	0.0121	CbGeAlD
Dasatinib—SIK2—liver—ulcerative colitis	0.00067	0.0107	CbGeAlD
Dasatinib—FRK—liver—ulcerative colitis	0.000653	0.0104	CbGeAlD
Dasatinib—CSK—smooth muscle tissue—ulcerative colitis	0.00065	0.0104	CbGeAlD
Dasatinib—ZAK—lymphoid tissue—ulcerative colitis	0.000642	0.0102	CbGeAlD
Dasatinib—ZAK—digestive system—ulcerative colitis	0.000634	0.0101	CbGeAlD
Dasatinib—RIPK2—epithelium—ulcerative colitis	0.000626	0.01	CbGeAlD
Dasatinib—LYN—lymphoid tissue—ulcerative colitis	0.000625	0.00998	CbGeAlD
Dasatinib—EPHA5—digestive system—ulcerative colitis	0.00062	0.00991	CbGeAlD
Dasatinib—BTK—lymphoid tissue—ulcerative colitis	0.000612	0.00978	CbGeAlD
Dasatinib—ERBB3—epithelium—ulcerative colitis	0.0006	0.00957	CbGeAlD
Dasatinib—STAT5B—liver—ulcerative colitis	0.000565	0.00902	CbGeAlD
Dasatinib—MAPK14—epithelium—ulcerative colitis	0.000558	0.00892	CbGeAlD
Dasatinib—EPHB3—digestive system—ulcerative colitis	0.000552	0.00881	CbGeAlD
Dasatinib—LIMK2—lymphoid tissue—ulcerative colitis	0.00054	0.00862	CbGeAlD
Dasatinib—MAPK14—smooth muscle tissue—ulcerative colitis	0.000538	0.00859	CbGeAlD
Dasatinib—EPHB4—epithelium—ulcerative colitis	0.000529	0.00845	CbGeAlD
Dasatinib—JAK2—epithelium—ulcerative colitis	0.000525	0.00839	CbGeAlD
Dasatinib—CSK—lymphoid tissue—ulcerative colitis	0.00052	0.0083	CbGeAlD
Dasatinib—EPHA2—epithelium—ulcerative colitis	0.000519	0.00829	CbGeAlD
Dasatinib—CSK—digestive system—ulcerative colitis	0.000513	0.0082	CbGeAlD
Dasatinib—HCK—lymphoid tissue—ulcerative colitis	0.000513	0.00819	CbGeAlD
Dasatinib—EPHB4—smooth muscle tissue—ulcerative colitis	0.00051	0.00814	CbGeAlD
Dasatinib—SIK3—liver—ulcerative colitis	0.000508	0.00811	CbGeAlD
Dasatinib—HCK—digestive system—ulcerative colitis	0.000507	0.00809	CbGeAlD
Dasatinib—JAK2—smooth muscle tissue—ulcerative colitis	0.000506	0.00809	CbGeAlD
Dasatinib—FYN—smooth muscle tissue—ulcerative colitis	0.000499	0.00798	CbGeAlD
Dasatinib—MAP4K5—smooth muscle tissue—ulcerative colitis	0.000488	0.00779	CbGeAlD
Dasatinib—RIPK2—digestive system—ulcerative colitis	0.000477	0.00761	CbGeAlD
Dasatinib—ZAK—liver—ulcerative colitis	0.000472	0.00754	CbGeAlD
Dasatinib—SIK1—lymphoid tissue—ulcerative colitis	0.000471	0.00752	CbGeAlD
Dasatinib—ERBB3—lymphoid tissue—ulcerative colitis	0.000462	0.00737	CbGeAlD
Dasatinib—LYN—liver—ulcerative colitis	0.00046	0.00734	CbGeAlD
Dasatinib—MAP3K2—lymphoid tissue—ulcerative colitis	0.000457	0.0073	CbGeAlD
Dasatinib—ERBB3—digestive system—ulcerative colitis	0.000456	0.00728	CbGeAlD
Dasatinib—YES1—smooth muscle tissue—ulcerative colitis	0.000451	0.0072	CbGeAlD
Dasatinib—BTK—liver—ulcerative colitis	0.000451	0.0072	CbGeAlD
Dasatinib—SRC—epithelium—ulcerative colitis	0.00045	0.00719	CbGeAlD
Dasatinib—TNK2—liver—ulcerative colitis	0.000444	0.00709	CbGeAlD
Dasatinib—PDGFRA—smooth muscle tissue—ulcerative colitis	0.000442	0.00706	CbGeAlD
Dasatinib—SRC—smooth muscle tissue—ulcerative colitis	0.000434	0.00692	CbGeAlD
Dasatinib—MAPK14—lymphoid tissue—ulcerative colitis	0.00043	0.00687	CbGeAlD
Dasatinib—FGR—lymphoid tissue—ulcerative colitis	0.000428	0.00684	CbGeAlD
Dasatinib—MAPK14—digestive system—ulcerative colitis	0.000425	0.00678	CbGeAlD
Dasatinib—FGR—digestive system—ulcerative colitis	0.000423	0.00676	CbGeAlD
Dasatinib—TESK1—liver—ulcerative colitis	0.000418	0.00667	CbGeAlD
Dasatinib—STK36—liver—ulcerative colitis	0.000411	0.00656	CbGeAlD
Dasatinib—JAK2—lymphoid tissue—ulcerative colitis	0.000405	0.00646	CbGeAlD
Dasatinib—EPHB4—digestive system—ulcerative colitis	0.000403	0.00643	CbGeAlD
Dasatinib—EPHA2—lymphoid tissue—ulcerative colitis	0.0004	0.00639	CbGeAlD
Dasatinib—JAK2—digestive system—ulcerative colitis	0.0004	0.00638	CbGeAlD
Dasatinib—FYN—lymphoid tissue—ulcerative colitis	0.000399	0.00637	CbGeAlD
Dasatinib—LIMK2—liver—ulcerative colitis	0.000397	0.00634	CbGeAlD
Dasatinib—EPHA2—digestive system—ulcerative colitis	0.000395	0.00631	CbGeAlD
Dasatinib—FYN—digestive system—ulcerative colitis	0.000394	0.0063	CbGeAlD
Dasatinib—MAP4K5—lymphoid tissue—ulcerative colitis	0.00039	0.00623	CbGeAlD
Dasatinib—CSF1R—smooth muscle tissue—ulcerative colitis	0.000389	0.00622	CbGeAlD
Dasatinib—STK35—liver—ulcerative colitis	0.000385	0.00615	CbGeAlD
Dasatinib—CSK—liver—ulcerative colitis	0.000382	0.00611	CbGeAlD
Dasatinib—HCK—liver—ulcerative colitis	0.000378	0.00603	CbGeAlD
Dasatinib—ABL2—liver—ulcerative colitis	0.000375	0.00599	CbGeAlD
Dasatinib—KIT—epithelium—ulcerative colitis	0.000367	0.00586	CbGeAlD
Dasatinib—YES1—lymphoid tissue—ulcerative colitis	0.00036	0.00575	CbGeAlD
Dasatinib—PDGFRB—epithelium—ulcerative colitis	0.000358	0.00572	CbGeAlD
Dasatinib—YES1—digestive system—ulcerative colitis	0.000356	0.00568	CbGeAlD
Dasatinib—RIPK2—liver—ulcerative colitis	0.000355	0.00567	CbGeAlD
Dasatinib—KIT—smooth muscle tissue—ulcerative colitis	0.000353	0.00564	CbGeAlD
Dasatinib—PDGFRA—lymphoid tissue—ulcerative colitis	0.000353	0.00564	CbGeAlD
Dasatinib—PDGFRA—digestive system—ulcerative colitis	0.000349	0.00557	CbGeAlD
Dasatinib—SIK1—liver—ulcerative colitis	0.000347	0.00554	CbGeAlD
Dasatinib—SRC—lymphoid tissue—ulcerative colitis	0.000347	0.00553	CbGeAlD
Dasatinib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000345	0.00551	CbGeAlD
Dasatinib—SRC—digestive system—ulcerative colitis	0.000342	0.00547	CbGeAlD
Dasatinib—ERBB3—liver—ulcerative colitis	0.00034	0.00543	CbGeAlD
Dasatinib—MAP3K2—liver—ulcerative colitis	0.000337	0.00537	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Budesonide—ulcerative colitis	0.000319	0.122	CbGdCrCtD
Dasatinib—MAPK14—liver—ulcerative colitis	0.000316	0.00505	CbGeAlD
Dasatinib—FGR—liver—ulcerative colitis	0.000315	0.00503	CbGeAlD
Dasatinib—LCK—liver—ulcerative colitis	0.000315	0.00503	CbGeAlD
Dasatinib—CSF1R—lymphoid tissue—ulcerative colitis	0.000311	0.00497	CbGeAlD
Dasatinib—ABL1—smooth muscle tissue—ulcerative colitis	0.000308	0.00491	CbGeAlD
Dasatinib—CSF1R—digestive system—ulcerative colitis	0.000307	0.00491	CbGeAlD
Dasatinib—FMO3—liver—ulcerative colitis	0.000304	0.00486	CbGeAlD
Dasatinib—EPHB4—liver—ulcerative colitis	0.0003	0.00479	CbGeAlD
Dasatinib—JAK2—liver—ulcerative colitis	0.000298	0.00476	CbGeAlD
Dasatinib—EPHA2—liver—ulcerative colitis	0.000294	0.0047	CbGeAlD
Dasatinib—FYN—liver—ulcerative colitis	0.000294	0.00469	CbGeAlD
Dasatinib—MAP4K5—liver—ulcerative colitis	0.000287	0.00458	CbGeAlD
Dasatinib—MAP3K3—liver—ulcerative colitis	0.000287	0.00458	CbGeAlD
Dasatinib—KIT—lymphoid tissue—ulcerative colitis	0.000283	0.00451	CbGeAlD
Dasatinib—KIT—digestive system—ulcerative colitis	0.000279	0.00446	CbGeAlD
Dasatinib—PDGFRB—lymphoid tissue—ulcerative colitis	0.000276	0.00441	CbGeAlD
Dasatinib—PDGFRB—digestive system—ulcerative colitis	0.000273	0.00435	CbGeAlD
Dasatinib—YES1—liver—ulcerative colitis	0.000265	0.00423	CbGeAlD
Dasatinib—ERBB3—Methyldopa—Mesalazine—ulcerative colitis	0.000261	0.0993	CbGdCrCtD
Dasatinib—CYP1B1—smooth muscle tissue—ulcerative colitis	0.000261	0.00416	CbGeAlD
Dasatinib—PDGFRA—liver—ulcerative colitis	0.00026	0.00415	CbGeAlD
Dasatinib—SRC—liver—ulcerative colitis	0.000255	0.00407	CbGeAlD
Dasatinib—ABL1—lymphoid tissue—ulcerative colitis	0.000246	0.00393	CbGeAlD
Dasatinib—ABL1—digestive system—ulcerative colitis	0.000243	0.00388	CbGeAlD
Dasatinib—MAP2K5—liver—ulcerative colitis	0.000235	0.00375	CbGeAlD
Dasatinib—CSF1R—liver—ulcerative colitis	0.000229	0.00366	CbGeAlD
Dasatinib—CYP1B1—lymphoid tissue—ulcerative colitis	0.000208	0.00333	CbGeAlD
Dasatinib—KIT—liver—ulcerative colitis	0.000208	0.00332	CbGeAlD
Dasatinib—CYP1B1—digestive system—ulcerative colitis	0.000206	0.00329	CbGeAlD
Dasatinib—PDGFRB—liver—ulcerative colitis	0.000203	0.00324	CbGeAlD
Dasatinib—CYP1A1—epithelium—ulcerative colitis	0.000191	0.00305	CbGeAlD
Dasatinib—ABL1—liver—ulcerative colitis	0.000181	0.00289	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—ulcerative colitis	0.000154	0.0588	CbGdCrCtD
Dasatinib—CYP1B1—liver—ulcerative colitis	0.000153	0.00245	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Betamethasone—ulcerative colitis	0.000152	0.0578	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—ulcerative colitis	0.000152	0.0578	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—ulcerative colitis	0.000148	0.0565	CbGdCrCtD
Dasatinib—CYP1A2—digestive system—ulcerative colitis	0.000147	0.00235	CbGeAlD
Dasatinib—CYP1A1—digestive system—ulcerative colitis	0.000145	0.00232	CbGeAlD
Dasatinib—CYP3A5—digestive system—ulcerative colitis	0.000142	0.00227	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisone—ulcerative colitis	0.000141	0.0536	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Prednisolone—ulcerative colitis	0.000137	0.0523	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Budesonide—ulcerative colitis	0.00013	0.0494	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Budesonide—ulcerative colitis	0.00013	0.0494	CbGdCrCtD
Dasatinib—ABCG2—liver—ulcerative colitis	0.000114	0.00182	CbGeAlD
Dasatinib—CYP1A2—liver—ulcerative colitis	0.00011	0.00175	CbGeAlD
Dasatinib—CYP1A1—liver—ulcerative colitis	0.000108	0.00173	CbGeAlD
Dasatinib—CYP3A4—digestive system—ulcerative colitis	0.000107	0.0017	CbGeAlD
Dasatinib—CYP3A5—liver—ulcerative colitis	0.000106	0.00169	CbGeAlD
Dasatinib—ABCB1—epithelium—ulcerative colitis	9.93e-05	0.00159	CbGeAlD
Dasatinib—PKMYT1—Danazol—Hydrocortisone—ulcerative colitis	9.28e-05	0.0353	CbGdCrCtD
Dasatinib—PKMYT1—Danazol—Prednisone—ulcerative colitis	7.99e-05	0.0304	CbGdCrCtD
Dasatinib—CYP3A4—liver—ulcerative colitis	7.95e-05	0.00127	CbGeAlD
Dasatinib—ABCB1—lymphoid tissue—ulcerative colitis	7.65e-05	0.00122	CbGeAlD
Dasatinib—ABCB1—digestive system—ulcerative colitis	7.55e-05	0.00121	CbGeAlD
Dasatinib—TESK1—Betamethasone—Hydrocortisone—ulcerative colitis	6.65e-05	0.0253	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Hydrocortisone—ulcerative colitis	6.65e-05	0.0253	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—ulcerative colitis	6.27e-05	0.0239	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—ulcerative colitis	6.27e-05	0.0239	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—ulcerative colitis	6.17e-05	0.0235	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—ulcerative colitis	6.17e-05	0.0235	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—ulcerative colitis	6.03e-05	0.023	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Triamcinolone—ulcerative colitis	6.03e-05	0.023	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—ulcerative colitis	5.72e-05	0.0218	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisone—ulcerative colitis	5.72e-05	0.0218	CbGdCrCtD
Dasatinib—ABCB1—liver—ulcerative colitis	5.63e-05	0.000899	CbGeAlD
Dasatinib—TESK1—Dexamethasone—Prednisolone—ulcerative colitis	5.59e-05	0.0213	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—ulcerative colitis	5.59e-05	0.0213	CbGdCrCtD
Dasatinib—Shock—Prednisolone—ulcerative colitis	5.3e-05	0.000474	CcSEcCtD
Dasatinib—Cough—Triamcinolone—ulcerative colitis	5.29e-05	0.000474	CcSEcCtD
Dasatinib—Oedema—Hydrocortisone—ulcerative colitis	5.26e-05	0.00047	CcSEcCtD
Dasatinib—Convulsion—Triamcinolone—ulcerative colitis	5.26e-05	0.00047	CcSEcCtD
Dasatinib—Tachycardia—Prednisolone—ulcerative colitis	5.25e-05	0.00047	CcSEcCtD
Dasatinib—Convulsion—Methylprednisolone—ulcerative colitis	5.24e-05	0.000469	CcSEcCtD
Dasatinib—Hypertension—Triamcinolone—ulcerative colitis	5.24e-05	0.000468	CcSEcCtD
Dasatinib—Pruritus—Mesalazine—ulcerative colitis	5.23e-05	0.000468	CcSEcCtD
Dasatinib—Hypertension—Methylprednisolone—ulcerative colitis	5.23e-05	0.000467	CcSEcCtD
Dasatinib—Infection—Hydrocortisone—ulcerative colitis	5.22e-05	0.000467	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisolone—ulcerative colitis	5.2e-05	0.000466	CcSEcCtD
Dasatinib—Shock—Hydrocortisone—ulcerative colitis	5.17e-05	0.000463	CcSEcCtD
Dasatinib—Myalgia—Triamcinolone—ulcerative colitis	5.16e-05	0.000462	CcSEcCtD
Dasatinib—Vomiting—Azathioprine—ulcerative colitis	5.16e-05	0.000462	CcSEcCtD
Dasatinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	5.16e-05	0.000461	CcSEcCtD
Dasatinib—Arthralgia—Methylprednisolone—ulcerative colitis	5.15e-05	0.000461	CcSEcCtD
Dasatinib—Myalgia—Methylprednisolone—ulcerative colitis	5.15e-05	0.000461	CcSEcCtD
Dasatinib—Eye disorder—Prednisone—ulcerative colitis	5.15e-05	0.00046	CcSEcCtD
Dasatinib—Anxiety—Methylprednisolone—ulcerative colitis	5.14e-05	0.000459	CcSEcCtD
Dasatinib—Tachycardia—Hydrocortisone—ulcerative colitis	5.13e-05	0.000459	CcSEcCtD
Dasatinib—Rash—Azathioprine—ulcerative colitis	5.12e-05	0.000458	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	5.12e-05	0.000458	CcSEcCtD
Dasatinib—Dermatitis—Azathioprine—ulcerative colitis	5.11e-05	0.000457	CcSEcCtD
Dasatinib—Flushing—Prednisone—ulcerative colitis	5.11e-05	0.000457	CcSEcCtD
Dasatinib—Skin disorder—Hydrocortisone—ulcerative colitis	5.11e-05	0.000457	CcSEcCtD
Dasatinib—Ill-defined disorder—Betamethasone—ulcerative colitis	5.11e-05	0.000457	CcSEcCtD
Dasatinib—Ill-defined disorder—Dexamethasone—ulcerative colitis	5.11e-05	0.000457	CcSEcCtD
Dasatinib—Discomfort—Triamcinolone—ulcerative colitis	5.1e-05	0.000456	CcSEcCtD
Dasatinib—Discomfort—Methylprednisolone—ulcerative colitis	5.09e-05	0.000455	CcSEcCtD
Dasatinib—Headache—Azathioprine—ulcerative colitis	5.09e-05	0.000455	CcSEcCtD
Dasatinib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	5.08e-05	0.000455	CcSEcCtD
Dasatinib—Diarrhoea—Mesalazine—ulcerative colitis	5.06e-05	0.000453	CcSEcCtD
Dasatinib—Anorexia—Hydrocortisone—ulcerative colitis	5.01e-05	0.000448	CcSEcCtD
Dasatinib—Angiopathy—Prednisone—ulcerative colitis	5e-05	0.000447	CcSEcCtD
Dasatinib—Confusional state—Methylprednisolone—ulcerative colitis	4.98e-05	0.000446	CcSEcCtD
Dasatinib—Immune system disorder—Prednisone—ulcerative colitis	4.97e-05	0.000445	CcSEcCtD
Dasatinib—Malaise—Dexamethasone—ulcerative colitis	4.96e-05	0.000444	CcSEcCtD
Dasatinib—Malaise—Betamethasone—ulcerative colitis	4.96e-05	0.000444	CcSEcCtD
Dasatinib—Oedema—Triamcinolone—ulcerative colitis	4.95e-05	0.000443	CcSEcCtD
Dasatinib—Vertigo—Dexamethasone—ulcerative colitis	4.95e-05	0.000442	CcSEcCtD
Dasatinib—Vertigo—Betamethasone—ulcerative colitis	4.95e-05	0.000442	CcSEcCtD
Dasatinib—Syncope—Dexamethasone—ulcerative colitis	4.94e-05	0.000442	CcSEcCtD
Dasatinib—Syncope—Betamethasone—ulcerative colitis	4.94e-05	0.000442	CcSEcCtD
Dasatinib—Arrhythmia—Prednisone—ulcerative colitis	4.92e-05	0.00044	CcSEcCtD
Dasatinib—Infection—Triamcinolone—ulcerative colitis	4.92e-05	0.00044	CcSEcCtD
Dasatinib—Hypotension—Hydrocortisone—ulcerative colitis	4.91e-05	0.000439	CcSEcCtD
Dasatinib—Infection—Methylprednisolone—ulcerative colitis	4.91e-05	0.000439	CcSEcCtD
Dasatinib—Dizziness—Mesalazine—ulcerative colitis	4.89e-05	0.000437	CcSEcCtD
Dasatinib—Shock—Triamcinolone—ulcerative colitis	4.87e-05	0.000436	CcSEcCtD
Dasatinib—Insomnia—Prednisolone—ulcerative colitis	4.87e-05	0.000436	CcSEcCtD
Dasatinib—Alopecia—Prednisone—ulcerative colitis	4.87e-05	0.000435	CcSEcCtD
Dasatinib—Shock—Methylprednisolone—ulcerative colitis	4.86e-05	0.000435	CcSEcCtD
Dasatinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	4.84e-05	0.000433	CcSEcCtD
Dasatinib—Loss of consciousness—Dexamethasone—ulcerative colitis	4.84e-05	0.000433	CcSEcCtD
Dasatinib—Loss of consciousness—Betamethasone—ulcerative colitis	4.84e-05	0.000433	CcSEcCtD
Dasatinib—Tachycardia—Triamcinolone—ulcerative colitis	4.83e-05	0.000432	CcSEcCtD
Dasatinib—Mental disorder—Prednisone—ulcerative colitis	4.82e-05	0.000432	CcSEcCtD
Dasatinib—Nausea—Azathioprine—ulcerative colitis	4.82e-05	0.000431	CcSEcCtD
Dasatinib—Tachycardia—Methylprednisolone—ulcerative colitis	4.82e-05	0.000431	CcSEcCtD
Dasatinib—Skin disorder—Methylprednisolone—ulcerative colitis	4.8e-05	0.000429	CcSEcCtD
Dasatinib—Erythema—Prednisone—ulcerative colitis	4.79e-05	0.000429	CcSEcCtD
Dasatinib—Malnutrition—Prednisone—ulcerative colitis	4.79e-05	0.000429	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.79e-05	0.000429	CcSEcCtD
Dasatinib—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.79e-05	0.000428	CcSEcCtD
Dasatinib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.78e-05	0.000427	CcSEcCtD
Dasatinib—Convulsion—Betamethasone—ulcerative colitis	4.77e-05	0.000427	CcSEcCtD
Dasatinib—Convulsion—Dexamethasone—ulcerative colitis	4.77e-05	0.000427	CcSEcCtD
Dasatinib—Insomnia—Hydrocortisone—ulcerative colitis	4.76e-05	0.000425	CcSEcCtD
Dasatinib—Hypertension—Betamethasone—ulcerative colitis	4.75e-05	0.000425	CcSEcCtD
Dasatinib—Hypertension—Dexamethasone—ulcerative colitis	4.75e-05	0.000425	CcSEcCtD
Dasatinib—Vomiting—Mesalazine—ulcerative colitis	4.7e-05	0.000421	CcSEcCtD
Dasatinib—Myalgia—Dexamethasone—ulcerative colitis	4.69e-05	0.000419	CcSEcCtD
Dasatinib—Myalgia—Betamethasone—ulcerative colitis	4.69e-05	0.000419	CcSEcCtD
Dasatinib—Anxiety—Betamethasone—ulcerative colitis	4.67e-05	0.000418	CcSEcCtD
Dasatinib—Anxiety—Dexamethasone—ulcerative colitis	4.67e-05	0.000418	CcSEcCtD
Dasatinib—Rash—Mesalazine—ulcerative colitis	4.66e-05	0.000417	CcSEcCtD
Dasatinib—Dermatitis—Mesalazine—ulcerative colitis	4.66e-05	0.000417	CcSEcCtD
Dasatinib—Headache—Mesalazine—ulcerative colitis	4.63e-05	0.000414	CcSEcCtD
Dasatinib—Discomfort—Betamethasone—ulcerative colitis	4.63e-05	0.000414	CcSEcCtD
Dasatinib—Discomfort—Dexamethasone—ulcerative colitis	4.63e-05	0.000414	CcSEcCtD
Dasatinib—Dyspepsia—Hydrocortisone—ulcerative colitis	4.63e-05	0.000414	CcSEcCtD
Dasatinib—Hypotension—Methylprednisolone—ulcerative colitis	4.62e-05	0.000413	CcSEcCtD
Dasatinib—Pain—Prednisolone—ulcerative colitis	4.6e-05	0.000412	CcSEcCtD
Dasatinib—Decreased appetite—Hydrocortisone—ulcerative colitis	4.57e-05	0.000409	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.54e-05	0.000406	CcSEcCtD
Dasatinib—Fatigue—Hydrocortisone—ulcerative colitis	4.53e-05	0.000405	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—ulcerative colitis	4.52e-05	0.000404	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.51e-05	0.000403	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.5e-05	0.000403	CcSEcCtD
Dasatinib—Pain—Hydrocortisone—ulcerative colitis	4.5e-05	0.000402	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—ulcerative colitis	4.49e-05	0.000402	CcSEcCtD
Dasatinib—Oedema—Betamethasone—ulcerative colitis	4.49e-05	0.000402	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—ulcerative colitis	4.48e-05	0.000401	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—ulcerative colitis	4.47e-05	0.0004	CcSEcCtD
Dasatinib—Infection—Betamethasone—ulcerative colitis	4.46e-05	0.000399	CcSEcCtD
Dasatinib—Infection—Dexamethasone—ulcerative colitis	4.46e-05	0.000399	CcSEcCtD
Dasatinib—Ill-defined disorder—Prednisone—ulcerative colitis	4.45e-05	0.000398	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—ulcerative colitis	4.44e-05	0.000397	CcSEcCtD
Dasatinib—Anaemia—Prednisone—ulcerative colitis	4.43e-05	0.000396	CcSEcCtD
Dasatinib—Shock—Betamethasone—ulcerative colitis	4.42e-05	0.000395	CcSEcCtD
Dasatinib—Shock—Dexamethasone—ulcerative colitis	4.42e-05	0.000395	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—ulcerative colitis	4.41e-05	0.000395	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—ulcerative colitis	4.41e-05	0.000394	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—ulcerative colitis	4.41e-05	0.000394	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—ulcerative colitis	4.4e-05	0.000393	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.4e-05	0.000393	CcSEcCtD
Dasatinib—Nausea—Mesalazine—ulcerative colitis	4.39e-05	0.000393	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—ulcerative colitis	4.38e-05	0.000392	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—ulcerative colitis	4.38e-05	0.000392	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—ulcerative colitis	4.36e-05	0.00039	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—ulcerative colitis	4.35e-05	0.000389	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—ulcerative colitis	4.34e-05	0.000388	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—ulcerative colitis	4.34e-05	0.000388	CcSEcCtD
Dasatinib—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.33e-05	0.000388	CcSEcCtD
Dasatinib—Malaise—Prednisone—ulcerative colitis	4.32e-05	0.000387	CcSEcCtD
Dasatinib—Vertigo—Prednisone—ulcerative colitis	4.31e-05	0.000385	CcSEcCtD
Dasatinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.3e-05	0.000385	CcSEcCtD
Dasatinib—Syncope—Prednisone—ulcerative colitis	4.3e-05	0.000385	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—ulcerative colitis	4.28e-05	0.000383	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—ulcerative colitis	4.28e-05	0.000383	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—ulcerative colitis	4.28e-05	0.000383	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—ulcerative colitis	4.27e-05	0.000382	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—ulcerative colitis	4.26e-05	0.000381	CcSEcCtD
Dasatinib—Pain—Triamcinolone—ulcerative colitis	4.23e-05	0.000379	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—ulcerative colitis	4.21e-05	0.000377	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—ulcerative colitis	4.2e-05	0.000375	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—ulcerative colitis	4.2e-05	0.000375	CcSEcCtD
Dasatinib—Urticaria—Hydrocortisone—ulcerative colitis	4.18e-05	0.000374	CcSEcCtD
Dasatinib—Abdominal pain—Hydrocortisone—ulcerative colitis	4.16e-05	0.000372	CcSEcCtD
Dasatinib—Body temperature increased—Hydrocortisone—ulcerative colitis	4.16e-05	0.000372	CcSEcCtD
Dasatinib—Convulsion—Prednisone—ulcerative colitis	4.15e-05	0.000372	CcSEcCtD
Dasatinib—Hypertension—Prednisone—ulcerative colitis	4.14e-05	0.00037	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.09e-05	0.000366	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.09e-05	0.000366	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—ulcerative colitis	4.08e-05	0.000365	CcSEcCtD
Dasatinib—Myalgia—Prednisone—ulcerative colitis	4.08e-05	0.000365	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—ulcerative colitis	4.08e-05	0.000365	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.07e-05	0.000364	CcSEcCtD
Dasatinib—Anxiety—Prednisone—ulcerative colitis	4.07e-05	0.000364	CcSEcCtD
Dasatinib—Insomnia—Betamethasone—ulcerative colitis	4.06e-05	0.000363	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—ulcerative colitis	4.06e-05	0.000363	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	4.05e-05	0.000363	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.04e-05	0.000361	CcSEcCtD
Dasatinib—Discomfort—Prednisone—ulcerative colitis	4.03e-05	0.000361	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—ulcerative colitis	3.97e-05	0.000355	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—ulcerative colitis	3.95e-05	0.000354	CcSEcCtD
Dasatinib—Dyspepsia—Betamethasone—ulcerative colitis	3.95e-05	0.000354	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—ulcerative colitis	3.93e-05	0.000352	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—ulcerative colitis	3.92e-05	0.000351	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—ulcerative colitis	3.91e-05	0.00035	CcSEcCtD
Dasatinib—Oedema—Prednisone—ulcerative colitis	3.91e-05	0.00035	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—ulcerative colitis	3.9e-05	0.000349	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—ulcerative colitis	3.9e-05	0.000349	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—ulcerative colitis	3.9e-05	0.000349	CcSEcCtD
Dasatinib—Infection—Prednisone—ulcerative colitis	3.89e-05	0.000348	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.88e-05	0.000347	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.88e-05	0.000347	CcSEcCtD
Dasatinib—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.87e-05	0.000347	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—ulcerative colitis	3.87e-05	0.000346	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—ulcerative colitis	3.87e-05	0.000346	CcSEcCtD
Dasatinib—Shock—Prednisone—ulcerative colitis	3.85e-05	0.000344	CcSEcCtD
Dasatinib—Pain—Betamethasone—ulcerative colitis	3.84e-05	0.000344	CcSEcCtD
Dasatinib—Pain—Dexamethasone—ulcerative colitis	3.84e-05	0.000344	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—ulcerative colitis	3.84e-05	0.000343	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—ulcerative colitis	3.82e-05	0.000342	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—ulcerative colitis	3.8e-05	0.00034	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—ulcerative colitis	3.78e-05	0.000338	CcSEcCtD
Dasatinib—Asthenia—Hydrocortisone—ulcerative colitis	3.77e-05	0.000337	CcSEcCtD
Dasatinib—Anorexia—Prednisone—ulcerative colitis	3.73e-05	0.000334	CcSEcCtD
Dasatinib—Pruritus—Hydrocortisone—ulcerative colitis	3.72e-05	0.000333	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—ulcerative colitis	3.7e-05	0.000331	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—ulcerative colitis	3.7e-05	0.000331	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.67e-05	0.000329	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.67e-05	0.000329	CcSEcCtD
Dasatinib—Hypersensitivity—Triamcinolone—ulcerative colitis	3.65e-05	0.000326	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.64e-05	0.000326	CcSEcCtD
Dasatinib—Diarrhoea—Hydrocortisone—ulcerative colitis	3.6e-05	0.000322	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—ulcerative colitis	3.57e-05	0.000319	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—ulcerative colitis	3.57e-05	0.000319	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.56e-05	0.000319	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—ulcerative colitis	3.56e-05	0.000318	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—ulcerative colitis	3.55e-05	0.000318	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—ulcerative colitis	3.55e-05	0.000318	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—ulcerative colitis	3.55e-05	0.000318	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—ulcerative colitis	3.55e-05	0.000318	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—ulcerative colitis	3.55e-05	0.000318	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—ulcerative colitis	3.54e-05	0.000317	CcSEcCtD
Dasatinib—Insomnia—Prednisone—ulcerative colitis	3.54e-05	0.000317	CcSEcCtD
Dasatinib—Pruritus—Triamcinolone—ulcerative colitis	3.5e-05	0.000313	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—ulcerative colitis	3.49e-05	0.000313	CcSEcCtD
Dasatinib—Dizziness—Hydrocortisone—ulcerative colitis	3.48e-05	0.000311	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—ulcerative colitis	3.44e-05	0.000308	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—ulcerative colitis	3.4e-05	0.000304	CcSEcCtD
Dasatinib—Rash—Prednisolone—ulcerative colitis	3.39e-05	0.000304	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—ulcerative colitis	3.39e-05	0.000303	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—ulcerative colitis	3.38e-05	0.000302	CcSEcCtD
Dasatinib—Fatigue—Prednisone—ulcerative colitis	3.37e-05	0.000302	CcSEcCtD
Dasatinib—Headache—Prednisolone—ulcerative colitis	3.37e-05	0.000302	CcSEcCtD
Dasatinib—Constipation—Prednisone—ulcerative colitis	3.35e-05	0.000299	CcSEcCtD
Dasatinib—Vomiting—Hydrocortisone—ulcerative colitis	3.34e-05	0.000299	CcSEcCtD
Dasatinib—Rash—Hydrocortisone—ulcerative colitis	3.32e-05	0.000297	CcSEcCtD
Dasatinib—Dermatitis—Hydrocortisone—ulcerative colitis	3.31e-05	0.000296	CcSEcCtD
Dasatinib—Headache—Hydrocortisone—ulcerative colitis	3.29e-05	0.000295	CcSEcCtD
Dasatinib—Dizziness—Triamcinolone—ulcerative colitis	3.27e-05	0.000293	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—ulcerative colitis	3.27e-05	0.000292	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—ulcerative colitis	3.22e-05	0.000288	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—ulcerative colitis	3.22e-05	0.000288	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—ulcerative colitis	3.22e-05	0.000288	CcSEcCtD
Dasatinib—Gastrointestinal pain—Prednisone—ulcerative colitis	3.2e-05	0.000286	CcSEcCtD
Dasatinib—Nausea—Prednisolone—ulcerative colitis	3.2e-05	0.000286	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—ulcerative colitis	3.18e-05	0.000284	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—ulcerative colitis	3.18e-05	0.000284	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—ulcerative colitis	3.15e-05	0.000282	CcSEcCtD
Dasatinib—Vomiting—Methylprednisolone—ulcerative colitis	3.14e-05	0.000281	CcSEcCtD
Dasatinib—Nausea—Hydrocortisone—ulcerative colitis	3.12e-05	0.000279	CcSEcCtD
Dasatinib—Rash—Triamcinolone—ulcerative colitis	3.12e-05	0.000279	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—ulcerative colitis	3.12e-05	0.000279	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—ulcerative colitis	3.11e-05	0.000279	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—ulcerative colitis	3.11e-05	0.000278	CcSEcCtD
Dasatinib—Urticaria—Prednisone—ulcerative colitis	3.11e-05	0.000278	CcSEcCtD
Dasatinib—Headache—Triamcinolone—ulcerative colitis	3.1e-05	0.000277	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—ulcerative colitis	3.09e-05	0.000277	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—ulcerative colitis	3.09e-05	0.000277	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—ulcerative colitis	3.09e-05	0.000277	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—ulcerative colitis	3.07e-05	0.000275	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—ulcerative colitis	3.07e-05	0.000275	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—ulcerative colitis	2.97e-05	0.000266	CcSEcCtD
Dasatinib—Dizziness—Betamethasone—ulcerative colitis	2.97e-05	0.000266	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—ulcerative colitis	2.94e-05	0.000263	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—ulcerative colitis	2.93e-05	0.000262	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—ulcerative colitis	2.88e-05	0.000258	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—ulcerative colitis	2.86e-05	0.000255	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—ulcerative colitis	2.86e-05	0.000255	CcSEcCtD
Dasatinib—Rash—Dexamethasone—ulcerative colitis	2.83e-05	0.000253	CcSEcCtD
Dasatinib—Rash—Betamethasone—ulcerative colitis	2.83e-05	0.000253	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—ulcerative colitis	2.83e-05	0.000253	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—ulcerative colitis	2.83e-05	0.000253	CcSEcCtD
Dasatinib—Headache—Dexamethasone—ulcerative colitis	2.81e-05	0.000252	CcSEcCtD
Dasatinib—Headache—Betamethasone—ulcerative colitis	2.81e-05	0.000252	CcSEcCtD
Dasatinib—Asthenia—Prednisone—ulcerative colitis	2.81e-05	0.000251	CcSEcCtD
Dasatinib—Pruritus—Prednisone—ulcerative colitis	2.77e-05	0.000248	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—ulcerative colitis	2.68e-05	0.000239	CcSEcCtD
Dasatinib—Nausea—Betamethasone—ulcerative colitis	2.67e-05	0.000239	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—ulcerative colitis	2.67e-05	0.000239	CcSEcCtD
Dasatinib—Dizziness—Prednisone—ulcerative colitis	2.59e-05	0.000231	CcSEcCtD
Dasatinib—Vomiting—Prednisone—ulcerative colitis	2.49e-05	0.000223	CcSEcCtD
Dasatinib—Rash—Prednisone—ulcerative colitis	2.47e-05	0.000221	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—ulcerative colitis	2.46e-05	0.00022	CcSEcCtD
Dasatinib—Headache—Prednisone—ulcerative colitis	2.45e-05	0.000219	CcSEcCtD
Dasatinib—Nausea—Prednisone—ulcerative colitis	2.32e-05	0.000208	CcSEcCtD
Dasatinib—FYN—Innate Immune System—IL6—ulcerative colitis	1.77e-06	1.26e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1B—ulcerative colitis	1.76e-06	1.26e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CD4—ulcerative colitis	1.76e-06	1.26e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL2—ulcerative colitis	1.76e-06	1.26e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL2—ulcerative colitis	1.76e-06	1.25e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—PTGS2—ulcerative colitis	1.75e-06	1.25e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—IL6—ulcerative colitis	1.75e-06	1.25e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—IL6—ulcerative colitis	1.74e-06	1.24e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—ADCY5—ulcerative colitis	1.74e-06	1.24e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MMP9—ulcerative colitis	1.73e-06	1.23e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—TP53—ulcerative colitis	1.72e-06	1.22e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—RELA—ulcerative colitis	1.72e-06	1.22e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NFKB1—ulcerative colitis	1.71e-06	1.22e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—IL6—ulcerative colitis	1.71e-06	1.22e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NFKB1—ulcerative colitis	1.71e-06	1.22e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—STAT3—ulcerative colitis	1.7e-06	1.21e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1B—ulcerative colitis	1.7e-06	1.21e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CDH1—ulcerative colitis	1.69e-06	1.21e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL2—ulcerative colitis	1.69e-06	1.2e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—IL6—ulcerative colitis	1.69e-06	1.2e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—STAT3—ulcerative colitis	1.68e-06	1.2e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—JAK2—ulcerative colitis	1.68e-06	1.19e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1B—ulcerative colitis	1.68e-06	1.19e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD4—ulcerative colitis	1.68e-06	1.19e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—NFKB1—ulcerative colitis	1.67e-06	1.19e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL2—ulcerative colitis	1.67e-06	1.19e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MMP9—ulcerative colitis	1.67e-06	1.19e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.67e-06	1.19e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—PTGS2—ulcerative colitis	1.66e-06	1.18e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NFKB1—ulcerative colitis	1.66e-06	1.18e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—STAT3—ulcerative colitis	1.66e-06	1.18e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PPARG—ulcerative colitis	1.65e-06	1.18e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NFKB1—ulcerative colitis	1.65e-06	1.18e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IFNG—ulcerative colitis	1.65e-06	1.17e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—NFKB1—ulcerative colitis	1.65e-06	1.17e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL6—ulcerative colitis	1.63e-06	1.16e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—RELA—ulcerative colitis	1.63e-06	1.16e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CXCL8—ulcerative colitis	1.62e-06	1.15e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL6—ulcerative colitis	1.6e-06	1.14e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—ulcerative colitis	1.59e-06	1.13e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TP53—ulcerative colitis	1.59e-06	1.13e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—JAK2—ulcerative colitis	1.59e-06	1.13e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NFKB1—ulcerative colitis	1.59e-06	1.13e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—ulcerative colitis	1.58e-06	1.12e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—STAT3—ulcerative colitis	1.57e-06	1.12e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NFKB1—ulcerative colitis	1.57e-06	1.11e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.56e-06	1.11e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—ulcerative colitis	1.56e-06	1.11e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—JAK2—ulcerative colitis	1.55e-06	1.1e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.55e-06	1.1e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—ulcerative colitis	1.55e-06	1.1e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—ADCY5—ulcerative colitis	1.54e-06	1.1e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—ulcerative colitis	1.54e-06	1.1e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	1.54e-06	1.1e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RELA—ulcerative colitis	1.54e-06	1.09e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—STAT3—ulcerative colitis	1.53e-06	1.09e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PPARG—ulcerative colitis	1.5e-06	1.07e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—STAT3—ulcerative colitis	1.5e-06	1.07e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CALM3—ulcerative colitis	1.5e-06	1.07e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—JAK2—ulcerative colitis	1.5e-06	1.07e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—STAT3—ulcerative colitis	1.5e-06	1.06e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—ulcerative colitis	1.49e-06	1.06e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—JAK2—ulcerative colitis	1.49e-06	1.06e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—STAT3—ulcerative colitis	1.48e-06	1.06e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—ulcerative colitis	1.48e-06	1.05e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—ulcerative colitis	1.48e-06	1.05e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—STAT3—ulcerative colitis	1.48e-06	1.05e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—ulcerative colitis	1.48e-06	1.05e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—ulcerative colitis	1.47e-06	1.05e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—ulcerative colitis	1.47e-06	1.05e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—ulcerative colitis	1.47e-06	1.04e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—ulcerative colitis	1.46e-06	1.04e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ABCB1—ulcerative colitis	1.46e-06	1.04e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—ulcerative colitis	1.46e-06	1.04e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—ulcerative colitis	1.46e-06	1.04e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—ulcerative colitis	1.46e-06	1.04e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.46e-06	1.04e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RELA—ulcerative colitis	1.45e-06	1.03e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NFKB1—ulcerative colitis	1.45e-06	1.03e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CXCL8—ulcerative colitis	1.45e-06	1.03e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.44e-06	1.03e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—RELA—ulcerative colitis	1.44e-06	1.02e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	1.43e-06	1.02e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—STAT3—ulcerative colitis	1.42e-06	1.01e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—STAT3—ulcerative colitis	1.42e-06	1.01e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—ulcerative colitis	1.41e-06	1e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—ulcerative colitis	1.41e-06	1e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—STAT3—ulcerative colitis	1.41e-06	1e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—ulcerative colitis	1.38e-06	9.84e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—ulcerative colitis	1.38e-06	9.79e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—JAK2—ulcerative colitis	1.37e-06	9.76e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—NFKB1—ulcerative colitis	1.37e-06	9.75e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CXCL8—ulcerative colitis	1.37e-06	9.75e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—STAT3—ulcerative colitis	1.37e-06	9.72e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ADCY5—ulcerative colitis	1.36e-06	9.71e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—ulcerative colitis	1.35e-06	9.62e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	1.35e-06	9.62e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1.33e-06	9.48e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—JAK2—ulcerative colitis	1.32e-06	9.42e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—ulcerative colitis	1.31e-06	9.35e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.31e-06	9.33e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	1.31e-06	9.32e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—ulcerative colitis	1.31e-06	9.32e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—ulcerative colitis	1.31e-06	9.31e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—ulcerative colitis	1.31e-06	9.31e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—JAK2—ulcerative colitis	1.3e-06	9.27e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—STAT3—ulcerative colitis	1.3e-06	9.27e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—ulcerative colitis	1.3e-06	9.26e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—ulcerative colitis	1.3e-06	9.25e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—ulcerative colitis	1.3e-06	9.25e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—STAT3—ulcerative colitis	1.3e-06	9.24e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—ulcerative colitis	1.3e-06	9.22e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NFKB1—ulcerative colitis	1.29e-06	9.22e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—ulcerative colitis	1.29e-06	9.19e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—ulcerative colitis	1.28e-06	9.14e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RELA—ulcerative colitis	1.28e-06	9.12e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—ulcerative colitis	1.27e-06	9.01e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RELA—ulcerative colitis	1.26e-06	8.98e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—ulcerative colitis	1.26e-06	8.95e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—JAK2—ulcerative colitis	1.25e-06	8.93e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—ulcerative colitis	1.24e-06	8.82e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	1.23e-06	8.78e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—STAT3—ulcerative colitis	1.23e-06	8.77e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NFKB1—ulcerative colitis	1.23e-06	8.72e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RELA—ulcerative colitis	1.22e-06	8.65e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—NFKB1—ulcerative colitis	1.21e-06	8.64e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL8—ulcerative colitis	1.21e-06	8.6e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—ulcerative colitis	1.21e-06	8.6e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—ulcerative colitis	1.2e-06	8.57e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RELA—ulcerative colitis	1.2e-06	8.54e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.2e-06	8.54e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—ulcerative colitis	1.19e-06	8.47e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL8—ulcerative colitis	1.19e-06	8.46e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—ulcerative colitis	1.18e-06	8.42e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	1.18e-06	8.39e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—ulcerative colitis	1.18e-06	8.37e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	1.18e-06	8.36e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—STAT3—ulcerative colitis	1.16e-06	8.28e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—ulcerative colitis	1.16e-06	8.26e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—ulcerative colitis	1.15e-06	8.22e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.15e-06	8.16e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—ulcerative colitis	1.15e-06	8.15e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—STAT3—ulcerative colitis	1.14e-06	8.09e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—ulcerative colitis	1.14e-06	8.09e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—ulcerative colitis	1.13e-06	8.06e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—ulcerative colitis	1.13e-06	8.05e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	1.12e-06	7.94e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	1.1e-06	7.86e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—STAT3—ulcerative colitis	1.1e-06	7.84e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—ulcerative colitis	1.1e-06	7.82e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—ulcerative colitis	1.09e-06	7.79e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—ulcerative colitis	1.09e-06	7.78e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—STAT3—ulcerative colitis	1.09e-06	7.76e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.09e-06	7.76e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—JAK2—ulcerative colitis	1.09e-06	7.72e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NFKB1—ulcerative colitis	1.08e-06	7.69e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—ulcerative colitis	1.08e-06	7.69e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—ulcerative colitis	1.08e-06	7.68e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	1.08e-06	7.67e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—ulcerative colitis	1.08e-06	7.66e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	1.08e-06	7.66e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—ulcerative colitis	1.08e-06	7.65e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—ulcerative colitis	1.07e-06	7.63e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NFKB1—ulcerative colitis	1.06e-06	7.57e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—ulcerative colitis	1.05e-06	7.5e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RELA—ulcerative colitis	1.05e-06	7.48e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—ulcerative colitis	1.05e-06	7.47e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—ulcerative colitis	1.04e-06	7.44e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—ulcerative colitis	1.04e-06	7.38e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—ulcerative colitis	1.04e-06	7.37e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—ulcerative colitis	1.03e-06	7.35e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.03e-06	7.32e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NFKB1—ulcerative colitis	1.02e-06	7.29e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—ulcerative colitis	1.02e-06	7.28e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—ulcerative colitis	1.02e-06	7.27e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—ulcerative colitis	1.02e-06	7.24e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NFKB1—ulcerative colitis	1.01e-06	7.2e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—STAT3—ulcerative colitis	1.01e-06	7.16e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—ulcerative colitis	9.95e-07	7.08e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—ulcerative colitis	9.94e-07	7.08e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	9.92e-07	7.06e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	9.9e-07	7.05e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—ulcerative colitis	9.9e-07	7.04e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—ulcerative colitis	9.82e-07	6.99e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—STAT3—ulcerative colitis	9.72e-07	6.91e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—ulcerative colitis	9.69e-07	6.89e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—JAK2—ulcerative colitis	9.61e-07	6.84e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—STAT3—ulcerative colitis	9.57e-07	6.81e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—ulcerative colitis	9.54e-07	6.79e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—ulcerative colitis	9.46e-07	6.73e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—ulcerative colitis	9.33e-07	6.64e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	9.33e-07	6.64e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RELA—ulcerative colitis	9.3e-07	6.62e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	9.26e-07	6.59e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—STAT3—ulcerative colitis	9.21e-07	6.55e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	9.2e-07	6.55e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—ulcerative colitis	9.15e-07	6.51e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—ulcerative colitis	9.1e-07	6.48e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—STAT3—ulcerative colitis	9.09e-07	6.47e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—ulcerative colitis	9.07e-07	6.45e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—ulcerative colitis	9.01e-07	6.41e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—ulcerative colitis	8.96e-07	6.37e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—ulcerative colitis	8.88e-07	6.32e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—ulcerative colitis	8.87e-07	6.31e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	8.86e-07	6.31e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—ulcerative colitis	8.77e-07	6.24e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	8.7e-07	6.19e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—ulcerative colitis	8.6e-07	6.12e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—ulcerative colitis	8.54e-07	6.08e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	8.48e-07	6.03e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—ulcerative colitis	8.43e-07	6e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—ulcerative colitis	8.41e-07	5.98e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—ulcerative colitis	8.38e-07	5.96e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—ulcerative colitis	8.13e-07	5.79e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—ulcerative colitis	8.13e-07	5.78e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—ulcerative colitis	8.01e-07	5.7e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—STAT3—ulcerative colitis	7.96e-07	5.67e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—ulcerative colitis	7.94e-07	5.65e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—ulcerative colitis	7.93e-07	5.64e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NFKB1—ulcerative colitis	7.85e-07	5.58e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—ulcerative colitis	7.69e-07	5.48e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—ulcerative colitis	7.62e-07	5.42e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	7.57e-07	5.39e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—ulcerative colitis	7.41e-07	5.28e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	7.38e-07	5.25e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—ulcerative colitis	7.31e-07	5.2e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—ulcerative colitis	7.3e-07	5.19e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	7.2e-07	5.12e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—STAT3—ulcerative colitis	7.05e-07	5.02e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—ulcerative colitis	7.03e-07	5e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—ulcerative colitis	7.03e-07	5e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—ulcerative colitis	6.94e-07	4.94e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	6.93e-07	4.93e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—ulcerative colitis	6.79e-07	4.83e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	6.72e-07	4.78e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—ulcerative colitis	6.68e-07	4.75e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—ulcerative colitis	6.54e-07	4.65e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—ulcerative colitis	6.49e-07	4.62e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—ulcerative colitis	6.43e-07	4.58e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	6.4e-07	4.55e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—ulcerative colitis	6.35e-07	4.52e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—ulcerative colitis	6.08e-07	4.32e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—ulcerative colitis	5.84e-07	4.15e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—ulcerative colitis	5.56e-07	3.96e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—ulcerative colitis	5.38e-07	3.83e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	5.11e-07	3.63e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	5.01e-07	3.56e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—ulcerative colitis	4.92e-07	3.5e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—ulcerative colitis	4.5e-07	3.21e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	3.94e-07	2.8e-06	CbGpPWpGaD
